trending Market Intelligence /marketintelligence/en/news-insights/trending/r8yrvtGpwA2qKEgtdvrbbQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Medical Transcription Billing registers preferred share offering

Amid Q1 APAC Fintech Funding Slump, Payment Companies Drove Investments

Paypal Well-Positioned To Gain Share In COVID-Related Digital Payments Shift

Digital Banking Battles Will Play Out In Southeast Asias Shopping Cart

Report: Kashkari Says Fed In Holding Pattern But Rate Cut Still Possible

Medical Transcription Billing registers preferred share offering

Medical TranscriptionBilling Corp. has filed a preliminary prospectus supplement to sellup to 63,040 additional non-convertible 11% series A cumulative redeemable perpetualpreferred shares.

The shares were first sold to the public Nov. 4, 2015.

If the company sells all 63,040 shares at the offering priceof $25.00 per share, it will receive a maximum of $1.6 million in gross proceedsand approximately $1.4 million in net proceeds, after deducting the underwritingdiscount and estimated offering expenses. The proceeds will be used to fund acquisitionsand growth, as well as for working capital and other general corporate purposes.

Dividends on the shares are payable monthly on a cumulative basisfrom July 1, when, as and if declared by the company's board, at the rate of 11%per annum of the $25.00 per share liquidation preference, equivalent to $2.75 perannum per share. The shares are subject to optional redemption by the company afterNov. 4, 2020, and upon a change of control.

Boenning & Scattergood Inc. is acting as lead book-runningmanager for the offering. Chardan Capital Markets LLC is serving as financial adviserto the company.